🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Medifast, Inc. MED R2K

Consumer Cyclical · Personal Services · United States
https://medifastinc.com

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

READ MORE ›
$12.53
-10.95% 1Y

Market & Price

Market Cap
$139.32M
Current Price
$12.53
High / Low (52W)
$15.22 / $9.53
Beta
0.57

Valuation

Stock P/E
-
Industry PE
22.37
Forward P/E
-
PEG Ratio
0.97
Book Value
$19.28
Price to Book
0.65
P/S
0.40
EV/EBITDA
6.12
Dividend Yield
-

Profitability & Returns

ROCE
-6.93%
ROE
-9.80%
ROA
-4.33%
Profit Margin
-5.79%
Op Margin
-7.21%
EPS (Latest Qtr)
$-0.19
EPS (TTM)
$-1.82

Balance Sheet & Liquidity

Debt/Equity
0.08
Quick Ratio
4.00
Current Ratio
4.80
Debt
$16.10M
Total Assets
$247.97M
Current Assets
$201.68M
Working Capital
$158.72M

Ownership

Promoter Holding
4.36%
Chg in Prom Hold
0.49%
FII / Inst Holding
85.25%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$-24.37M
Total Revenue (TTM)
$346.10M
EBITDA
$-3.98M
Free Cash Flow
$4.41M
Operating Cash Flow
$3.72M
Shares Outstanding
11.12M
Gross Margin
70.12%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
-37.74%
Profit 5Y
-37.67%
Revenue (YoY)
-34.30%
Earnings (YoY)
-

PROS

  • Generates positive free cash flow.

CONS

  • Revenue declined at -37.7% CAGR over 5 years.
  • Earnings shrank at -37.7% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Cyclical).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MED Medifast, Inc. R2K 12.53 - $139.32M - -6.93% -9.80% -37.74% -37.67%
2 AMZN Amazon.com, Inc. NDXSPXAI 270.64 31.65 $2.91T - 16.60% 24.29% 11.73% 984.47%
3 TSLA Tesla, Inc. NDXSPXAI 435.79 399.81 $1.64T - 5.29% 4.90% 5.19% -32.94%
4 HD The Home Depot, Inc. SPX 317.14 22.52 $316.23B 2.94% 28.92% 128.38% 1.52% -6.11%
5 MCD McDonald's Corporation SPX 279.20 23.04 $198.37B 2.66% 22.63% - 5.06% 11.50%
6 TJX The TJX Companies, Inc. SPX 154.75 30.11 $171.12B 1.24% 32.91% 61.25% 6.53% 16.24%
7 BKNG Booking Holdings Inc. NDXSPX 167.43 22.09 $129.74B 0.96% 67.24% - 16.35% 20.90%
8 LOW Lowe's Companies, Inc. SPX 214.36 18.12 $120.26B 2.24% 29.62% - -3.85% 1.11%
9 PDD PDD Holdings Inc. NDX 84.44 8.87 $120.19B - 28.69% 25.40% 49.00% 45.85%
Ad space

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------------------------417.60M453.33M390.40M348.98M296.19M235.87M174.74M168.56M-115.73M105.56M89.41M75.10M76.04M
Cost of Revenue -----------------------------------31.48M28.91M27.25M22.96M24.29M
Gross Profit 53.17M49.16M45.22M53.19M53.23M52.16M47.08M52.89M57.61M58.18M59.13M74.81M88.80M107.20M109.09M125.15M140.71M142.93M128.07M135.24M159.30M204.04M199.24M248.55M293.71M307.06M302.29M321.68M282.85M246.39M210.72M177.38M127.29M123.44M-84.25M76.64M62.16M52.14M51.76M
Operating Expenses -----------------------------------85.51M77.71M66.24M59.94M55.05M
Operating Income 8.66M7.97M-6.27M5.02M8.95M-8.61M11.31M10.23M-14.68M17.11M17.47M-24.71M27.36M20.26M-23.53M28.10M44.56M-52.80M61.43M55.17M55.09M48.96M48.16M53.51M38.71M25.51M7.94M-7.88M--1.26M-1.07M-4.08M-7.80M-3.29M
EBITDA -----------------------------------2.02M2.98M-629.00K-4.34M188.00K
Interest Expense ----------------------------------------
Pretax Income -----------------------------------526.00K2.88M-2.66M-6.38M-1.94M
Tax Provision -----------------------------------1.30M395.00K-396.00K11.74M181.00K
Net Income 6.25M5.51M3.86M4.26M3.40M6.07M4.11M6.14M7.58M6.69M7.31M12.22M14.13M13.78M15.65M20.75M21.38M15.90M19.88M18.48M21.93M34.45M27.99M41.06M46.96M41.98M41.78M39.11M36.16M39.97M30.28M23.13M8.32M-8.15M--772.00K2.48M-2.26M-18.12M-2.12M
Diluted EPS 0.510.460.330.360.290.510.340.510.630.550.601.011.161.141.301.701.751.321.661.561.862.912.363.463.963.563.593.423.273.672.772.120.76-0.75--0.070.22-0.21-1.65-0.19

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------------1.60B1.07B602.46M385.79M
Cost of Revenue -------------458.16M296.20M157.84M110.60M
Gross Profit 124.39M192.47M224.50M235.91M240.57M209.21M201.31M205.66M227.81M379.90M536.86M697.82M-1.14B775.85M444.62M275.19M
Operating Expenses -------------955.61M649.45M441.75M289.40M
Operating Income 18.50M31.64M27.38M27.14M38.41M30.25M28.68M26.86M39.63M69.06M91.04M134.16M-184.81M126.40M2.88M-14.21M
EBITDA -------------195.74M139.51M15.59M29.00K
Interest Expense -------------701.00K---
Pretax Income -------------184.06M128.80M3.79M-5.64M
Tax Provision -------------40.49M29.38M1.70M13.03M
Net Income 11.36M19.61M18.54M15.88M23.97M13.18M20.06M17.84M27.72M55.79M77.92M102.86M-143.57M99.42M2.09M-18.67M
Diluted EPS 0.771.351.311.161.731.031.661.492.294.626.438.6813.8912.739.100.19-
R&D Expense -----1.30M1.80M2.00M1.50M2.20M2.70M2.80M4.40M4.50M4.60M4.60M4.30M

Compounded Sales Growth

5 Years:-37.74%
1 Year:-34.30%

Compounded Profit Growth

5 Years:-37.67%
1 Year:-

Stock Price Performance

1 Year:-10.95%
6 Months:+14.85%
3 Months:+18.99%
1 Month:+14.74%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --94.06M105.67M130.25M132.65M115.91M116.12M121.22M145.93M169.43M194.65M276.08M-316.21M309.91M284.21M247.97M
Current Assets --------------222.78M224.03M214.40M201.68M
Cash & Equivalents 973.00K10.60M17.16M14.26M39.94M36.38M24.46M42.04M52.44M75.08M81.36M76.97M163.72M-87.69M94.44M90.93M89.30M
Inventory --------------118.86M54.59M42.42M20.23M
Receivables ------------------
Total Liabilities --22.10M32.26M39.47M34.23M35.43M27.53M25.20M37.35M60.32M89.82M118.84M-161.17M108.43M74.10M49.05M
Current Liabilities --15.96M20.26M28.75M27.10M26.94M23.56M24.42M37.14M60.32M79.39M111.35M-140.89M92.30M64.16M42.96M
Long Term Debt --4.65M3.34M3.11M0------------
Total Debt --------------26.05M22.01M16.12M10.69M
Total Equity 34.07M47.82M71.96M73.40M90.79M98.42M80.48M88.58M96.02M106.56M109.11M104.83M157.25M-155.04M201.48M210.11M198.92M
Shares Outstanding --------------10.93M10.90M10.94M10.99M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 19.16M28.77M34.87M40.26M42.36M25.54M29.41M25.35M43.24M60.82M84.26M145.20M-194.57M147.66M24.48M6.86M
Investing Cash Flow -8.62M-23.54M-16.87M-11.66M-22.60M-2.52M-189.00K-2.04M-3.16M-1.20M-6.33M-1.28M--11.41M-61.05M-26.52M-7.93M
Financing Cash Flow -908.00K1.33M-20.90M-2.92M-23.31M-34.94M-11.73M-12.92M-17.36M-53.33M-82.32M-57.14M--199.58M-79.79M-1.51M-564.00K
Capital Expenditure -5.12M-12.05M-14.27M-8.13M-11.39M-7.02M-2.82M-2.88M-3.24M-4.94M-10.06M-5.89M--16.68M-6.48M-7.45M-5.61M
Free Cash Flow 14.04M16.71M20.60M32.14M30.97M18.51M26.59M22.47M39.99M55.88M74.20M139.31M-177.89M141.17M17.02M1.25M
Net Change in Cash --------------16.43M6.82M-3.56M-1.63M
Share Buybacks 102.00K35.00K20.39M2.76M20.08M33.89M10.52M--30.00M33.11M5.00M56.00M126.44M3.60M00
Dividends Paid -------11.89M15.39M23.16M35.40M53.19M63.86M71.62M73.02M715.00K195.00K

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------71.3%72.4%73.8%71.3%
Operating Margin % -------------11.6%11.8%0.5%-3.7%
Net Margin % -------------9.0%9.3%0.3%-4.8%
ROE % 23.8%27.3%25.3%17.5%24.4%16.4%22.6%18.6%26.0%51.1%74.3%65.4%-92.6%49.3%1.0%-9.4%
ROCE % -40.5%32.1%26.7%36.4%34.0%31.0%27.7%36.4%63.3%79.0%81.4%-105.4%58.1%1.3%-6.9%

Shareholding Pattern

Insiders
4.36%
Institutions
85.25%
Public Float
89.14%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 8.49% 944.45K $11.83M
2 Renaissance Technologies, LLC 6.96% 773.71K $9.69M
3 Steamboat Capital Partners, Llc 6.36% 707.59K $8.87M
4 Charles Schwab Investment Management, Inc. 5.68% 631.54K $7.91M
5 Vanguard Capital Management LLC 4.00% 444.47K $5.57M
6 Dimensional Fund Advisors LP 3.25% 361.76K $4.53M
7 Two Sigma Investments, LP 3.04% 338.16K $4.24M
8 Morgan Stanley 2.93% 325.31K $4.08M
9 Geode Capital Management, LLC 2.28% 253.31K $3.17M
10 Man Group PLC 2.12% 236.21K $2.96M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MED

No recent headlines available.

Explore More

📊 Consumer Cyclical Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks